Implementing "Gut-Selective" Drug Delivery Systems and Nanotechnology for Enhanced Bioavailability in the 2026 Opioid Induced Constipation Drug Sector
In early 2026, the application of nanotechnology is allowing for the creation of "Smart Capsules" that release OIC medications only when they reach specific pH levels or enzymatic triggers in the colon. These 2026 drug delivery systems maximize the local concentration of the treatment where it is needed most, significantly reducing the required systemic dose and the potential for side effects....
ไลค์
1
0 ความคิดเห็น 0 แชร์ 169 ยอดวิว 0 รีวิว